(CIDRAP News) The United States' food supply makes an attractive target for terrorists, and people in the food industry need to talk more frankly about the risks, bioterrorism expert Michael T. Osterholm, PhD, MPH, said in a Minneapolis speech yesterday.
(CIDRAP News) Federal health officials project that about half of the estimated 10 million health and emergency response workers targeted for the second round of smallpox vaccinations will refuse the shots.
(CIDRAP News) – Federal health officials today released a lengthy plan for dealing with the potentially overwhelming threat of an influenza pandemic like those that occurred three times in the last century.
(CIDRAP News) In a bid to limit the threat of an influenza pandemic, the Department of Health and Human Services (HHS) is awarding a contract to Aventis Pasteur Inc. to make 2 million doses of a vaccine for humans to protect against H5N1 avian influenza.
(CIDRAP News) The vaccine supply for the soon-to-begin influenza season is suddenly in serious condition with news that Chiron Corp., maker of about half the US supply, has been ordered to stop production by British health authorities and will not be shipping its doses.
(CIDRAP News) – Amid the devastation left by hurricane Katrina on the US Gulf Coast, fears of infectious disease outbreaks have added to the distress. Some of those concerns are solidly grounded, while others are less so, disease experts say.
(CIDRAP News) A not-yet-released version of the Bush administration's plan for dealing with an influenza pandemic predicts that such an event could exact an enormous toll in life and wealth, according to recent newspaper reports.
(CIDRAP News) – A national conference scheduled Feb 14 and 15 in Minneapolis will give business leaders an opportunity to learn from experts about the risk of pandemic influenza and help figure out how their industries can prepare for it.
(CIDRAP News) – A mathematical modeling study suggests that a modestly effective vaccine could keep an influenza pandemic from striking more than 10% of the US population, but only if large amounts of vaccine were distributed quickly and the virus was not too highly contagious.